Scarica l'app Stockscreener
3.90
4.00%
0.15
Precedente Chiudi:
$3.75
Aprire:
$3.84
Volume 24 ore:
14,464
Relative Volume:
0.60
Capitalizzazione di mercato:
$3.88M
Reddito:
-
Utile/perdita netta:
$-7.29M
Rapporto P/E:
-0.16
EPS:
-24.3686
Flusso di cassa netto:
$-6.81M
1 W Prestazione:
+1.83%
1M Prestazione:
+10.42%
6M Prestazione:
+2.09%
1 anno Prestazione:
-22.92%
Intervallo 1D:
$3.73
$3.92
Intervallo di 1 settimana:
$3.63
$4.03
Portata 52W:
$2.36
$5.30
Heartsciences Inc Stock (HSCS) Company Profile
Nome
Heartsciences Inc
Settore
Industria
Telefono
682-237-7781
Indirizzo
550 RESERVE ST, SUITE 360, SOUTHLAKE
Confronta HSCS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HSCS
Heartsciences Inc
|
3.90 | 3.88M | 0 | -7.29M | -6.81M | -24.37 |
|
ABT
Abbott Laboratories
|
136.26 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.78 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
396.74 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
88.75 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.18 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Heartsciences Inc Borsa (HSCS) Ultime notizie
FDA Grants Breakthrough Device Designation for HeartSciences' AI-ECG Algorithm - Diagnostic and Interventional Cardiology
HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis - Investing News Network
HeartSciences recesives FDA BDD for Aortic Stenosis ECG algorithm - MSN
HeartSciences (HSCS) Gains FDA Breakthrough Status for AI ECG Al - GuruFocus
Heart Test Laboratories Receives FDA Breakthrough Designation - TipRanks
HeartSciences (HSCS) Gains FDA Breakthrough Status for AI ECG Algorithm | HSCS Stock News - GuruFocus
Revolutionary AI Algorithm Detects Silent Killer Heart Disease 2 Years Earlier, FDA Fast-Tracks Approval - Stock Titan
Heart Test Laboratories Files Certificate for Preferred Stock - TipRanks
HeartSciences announces grant by USPTO for ECG assessment of heart function - TipRanks
HeartSciences Inc. Announces the Grant by the United States Patent and Trademark Office of A foundational Patent Covering the Establishing the Estimation of Echocardiography parameters Indicative of Heart Function Using an ECG - marketscreener.com
Heart Test Laboratories Secures Foundational Patent for AI-ECG - TipRanks
HeartSciences (HSCS) Strengthens IP Portfolio with New Patent Grant | HSCS Stock News - GuruFocus
HeartSciences Inc. Secures Foundational Patent for AI-Driven ECG Technology Enhancing Heart Function Detection - Nasdaq
Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences' Patent Portfolio and IP Value - The Manila Times
Revolutionary AI Patent: HeartSciences Transforms ECG Technology for Earlier Heart Disease Detection - Stock Titan
HeartSciences signs first MyoVista Insights platform customer - Yahoo Finance
HeartSciences Inc. Signs First MyVista Insights Platform Customer - marketscreener.com
HeartSciences Signs First MyoVista Insights(TM) Platform Customer - marketscreener.com
HeartSciences (HSCS) Secures First Client for MyoVista Insights in the UK | HSCS Stock News - GuruFocus
HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone - GlobeNewswire
HeartSciences amends corporate articles By Investing.com - Investing.com Canada
HeartSciences amends corporate articles - Investing.com
Heart Test Laboratories Announces $15M Securities Offering - TipRanks
Heart Test Labs Granted Nasdaq Compliance Extension - MSN
HeartSciences' CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2025 - The Manila Times
HeartSciences Unveils Game-Changing AI-Powered ECG Platform: CEO Presents Investment Opportunity Tomorrow - Stock Titan
HeartSciences receives Nasdaq compliance extension - Investing.com
HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025Featuring CEO Andrew Simpson - The Manila Times
HeartSciences (HSCS) Enhances Team with Key Scientific Advisory Appointments | HSCS Stock News - GuruFocus
HeartSciences Inc. Expands Scientific Advisory Board with Three New Appointments to Enhance AI-Driven Cardiac Care - Nasdaq
HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board - The Manila Times
HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results - ADVFN
HeartSciences launches MyoVista Insights platform - TipRanks
HeartSciences (HSCS) Unveils MyoVista Insights Platform | HSCS S - GuruFocus
HeartSciences (HSCS) Unveils MyoVista Insights Platform | HSCS Stock News - GuruFocus
HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program - The Manila Times
Lifestyle Icon Martha Stewart Confirmed As Vivid Sydney 2025's Global Storyteller - Barchart.com
This AI Company Is Solving A 100+ Year-Old Health Problem - Barchart.com
Northstar Secures 15-Year Lease Extension For Delta, BC Facility - Barchart.com
/R E P E A T -- LASSONDE INDUSTRIES INC. WILL HOLD A CONFERENCE CALL TO DISCUSS ITS Q4 AND FISCAL 2024 RESULTS/ - Barchart.com
HeartSciences faces Nasdaq delisting over equity shortfall By Investing.com - Investing.com Canada
HeartSciences faces Nasdaq delisting over equity shortfall - Investing.com
HeartSciences Reports Third Quarter Fiscal 2025 Financial Results and Business Update on AI-Powered ECG Innovations - Nasdaq
Heartsciences Inc Azioni (HSCS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.52%
0.92%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):